Literature DB >> 34917204

Catheter-based biopsy leading to early surgical intervention of the pulmonary artery intimal sarcoma.

Hideo Takahashi1, Takayuki Onishi1, Tomo Ando1, Tetsuya Tobaru1.   

Abstract

Pulmonary artery intimal sarcoma (PAIS) is an extremely rare disease that portends a dismal prognosis. To reach a diagnosis, several diagnostic measures are performed but pathological confirmation is required for an ultimate diagnosis. We report a case where a catheter-based, less invasive approach led to the diagnosis and curative intervention for PAIS. <Learning objective: Catheter-based biopsy could lead to early diagnosis of pulmonary artery intimal sarcoma and surgical intervention that would improve the outcome.>.
© 2021 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biopsy; Pulmonary artery intimal sarcoma

Year:  2021        PMID: 34917204      PMCID: PMC8642630          DOI: 10.1016/j.jccase.2021.04.016

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  4 in total

1.  Long-term survival of a pulmonary artery sarcoma produced by aggressive surgical resection and adjuvant chemoradiotherapy.

Authors:  Atsushi Nakahira; Hitoshi Ogino; Hiroaki Sasaki; Nobuyuki Katakami
Journal:  Eur J Cardiothorac Surg       Date:  2007-06-13       Impact factor: 4.191

2.  Surgical treatment of primary pulmonary sarcomas.

Authors:  E A Bacha; C D Wright; H C Grillo; J C Wain; A Moncure; S B Keel; D M Donahue; D J Mathisen
Journal:  Eur J Cardiothorac Surg       Date:  1999-04       Impact factor: 4.191

Review 3.  Primary cardiac angiosarcoma: case report and review of the literature.

Authors:  Kizhake C Kurian; Dana Weisshaar; Hemal Parekh; Gerald J Berry; Bruce Reitz
Journal:  Cardiovasc Pathol       Date:  2006 Mar-Apr       Impact factor: 2.185

4.  Sarcomas of the great vessels. A clinicopathologic study.

Authors:  A P Burke; R Virmani
Journal:  Cancer       Date:  1993-03-01       Impact factor: 6.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.